A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
How I used psychology to come back from the worst year of my life
5
The distant world that is our best hope of finding alien life
6
The ‘doomsday’ glacier’s giant ice shelf is about to break away
7
Epic dreaming is leaving people exhausted and distressed
8
The 3 things you need to know about protein, according to an expert
9
Putting CO2 into rocks and getting hydrogen out is climate double win
10
Women’s better memories may delay Alzheimer’s diagnosis by years
